First author | Year | Patients (n) | Indication (T/P) | Dosage | Duration | Success rate | Adverse events |
---|---|---|---|---|---|---|---|
Lecornu [57] | 1974 | 25 children | T: compl. and uncompl. UTI | 50–400 mg/d as suspension | 4–12 days | 72% | 8% nausea |
0–13 years | |||||||
Roussel [58] | 1974 | 24 children | T: compl. and uncompl. UTI | 10Â mg/kg/d as suspension | 10Â days- 6Â months | 79% | 0% |
7 days–6 months | |||||||
Raynaud [59] | 1974 | 19 children | T: compl. and uncompl. UTI | 10Â mg/kg/d as suspension | 20Â days | 69% | 10% nausea |
0–10 years | |||||||
Luckel [60] | 1975 | 25 children | P: compl. and uncompl. UTI | 10–20 mg/kg/d as suspension | 17–55 days | 83% | 0% |
0–8.5 years | |||||||
Viville [61] | 1975 | 22 children | P: compl. UTI | 10–30 mg/kg/d as suspension | 3–6 months | 86% | 0% |
2Â months-17Â years | |||||||
Chable [62] | 1975 | 28 children | T: compl. and uncompl. UTI | 10–20 mg/kg/d as suspension | 10 days | 81% | 0% |
2Â month-14.5Â years | |||||||
Battin [63] | 1975 | 30 children | P: compl. and uncompl. UTI | 10Â mg/kg/d as suspension | 6Â weeks | 90% | 0% |
2Â month-10Â years | |||||||
Sorez [64] | 1975 | 30 children | T: compl. and uncompl. UTI | 10–25 mg/kg/d as suspension | 10 – 17 days | 73.7% uncompl. UTI 40% compl. UTI | 0% |
10Â days-8Â years | |||||||
Neimann [65] | 1975 | 21 children | T/P: compl. and uncompl. UTI | 25–400 mg/d as suspension | 4 days-4 months | 90% | 10% nausea |
26Â days-8Â years | |||||||
Machecourt [66] | 1976 | 23 children | T: compl. and uncompl. UTI | 10–20 mg/kg/d as suspension | 10 days | 91% | 0% |
21Â days-14Â years | |||||||
Lambert-Zechovsky [24] | 1987 | 12 children | T: uncompl. UTI | 20Â mg/kg/d as suspension | 10Â days | 66% (91% incl. non-compliance) | - |
aver. 4Â years |